PF-Atlas › Clinical Trials › NCT03898284
Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis
Impulse Oscillometry · Not specified
Registry ID
NCT03898284
Phase
Not specified
Status
Completed
Drug / intervention
Impulse Oscillometry
Sponsor
University Hospital, Tours
Start
2019-04-23
Enrollment
54
Locations
4
About this trial
A 5-point decline of forced vital capacity expressed as % predicted, over 6 months, is the current definition of disease progression (fast decline in lung function) in idiopathic pulmonary fibrosis. There is a need for techniques allowing to characterize disease progression earlier, so that treatment may be adapted as early as possible in the lack of a response. Hypothesis. Our hypothesis is that 3-month changes of lung function parameters measured by a novel technique, impulse oscillometry, predicts 6-month changes in forced vital capacity in idiopathic pulmonary fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03898284 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.